Literature DB >> 15756514

The use of clonidine for severe and intractable sleep problems in children with neurodevelopmental disorders--a case series.

Antonina Ingrassia1, Jeremy Turk.   

Abstract

This paper reports on the use of clonidine for the treatment of severe sleep problems associated with behavioural difficulties in children with neurodevelopmental disabilities. Data were obtained from reviewing the case notes of a series of six children with neurodevelopmental disorders of different nature and severity, presenting with problematic sleep. All children in this group showed maintained improvements in their sleep pattern following the use of clonidine with only mild side-effects reported.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756514     DOI: 10.1007/s00787-005-0424-4

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  27 in total

Review 1.  Review of strategies for treating sleep problems in persons with severe or profound mental retardation or multiple handicaps.

Authors:  G E Lancioni; M F O'Reilly; G Basili
Journal:  Am J Ment Retard       Date:  1999-03

2.  Pro-convulsant effects of oral melatonin in neurologically disabled children.

Authors:  S H Sheldon
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

3.  Melatonin appears ineffective in children with intellectual deficits and fragmented sleep: six "N of 1" trials.

Authors:  P Camfield; K Gordon; J Dooley; C Camfield
Journal:  J Child Neurol       Date:  1996-07       Impact factor: 1.987

4.  Sleep problems in handicapped children: a preliminary study.

Authors:  J Clements; L Wing; G Dunn
Journal:  J Child Psychol Psychiatry       Date:  1986-05       Impact factor: 8.982

5.  A double-blind drug trial of treatment in young children with waking problems.

Authors:  N Richman
Journal:  J Child Psychol Psychiatry       Date:  1985-07       Impact factor: 8.982

Review 6.  Clonidine for sleep disturbances associated with attention-deficit hyperactivity disorder.

Authors:  T E Wilens; J Biederman; T Spencer
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Mar-Apr       Impact factor: 8.829

7.  Sleep problems in young children.

Authors:  N Richman
Journal:  Arch Dis Child       Date:  1981-07       Impact factor: 3.791

8.  Sleep problems in early childhood: continuities, predictive factors, and behavioral correlates.

Authors:  B Zuckerman; J Stevenson; V Bailey
Journal:  Pediatrics       Date:  1987-11       Impact factor: 7.124

9.  Behavioural treatment for sleep problems in children with severe learning disabilities and challenging daytime behaviour: effect on sleep patterns of mother and child.

Authors:  L Wiggs; G Stores
Journal:  J Sleep Res       Date:  1998-06       Impact factor: 3.981

10.  Melatonin treatment in an institutionalised child with psychomotor retardation and an irregular sleep-wake pattern.

Authors:  G Pillar; A Etzioni; E Shahar; P Lavie
Journal:  Arch Dis Child       Date:  1998-07       Impact factor: 3.791

View more
  12 in total

Review 1.  Pharmacological therapies for Angelman syndrome.

Authors:  Wen-Hann Tan; Lynne M Bird
Journal:  Wien Med Wochenschr       Date:  2016-01-12

Review 2.  Sleep in Infants and Children with Prenatal Alcohol Exposure.

Authors:  Sarah M Inkelis; Jennifer D Thomas
Journal:  Alcohol Clin Exp Res       Date:  2018-05-31       Impact factor: 3.455

3.  Prevalence, nature, and correlates of sleep problems among children with fragile X syndrome based on a large scale parent survey.

Authors:  Rebecca Kronk; Ellen E Bishop; Melissa Raspa; Julie O Bickel; Daniel A Mandel; Donald B Bailey
Journal:  Sleep       Date:  2010-05       Impact factor: 5.849

Review 4.  Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Authors:  Elizabeth M Berry-Kravis; Lothar Lindemann; Aia E Jønch; George Apostol; Mark F Bear; Randall L Carpenter; Jacqueline N Crawley; Aurore Curie; Vincent Des Portes; Farah Hossain; Fabrizio Gasparini; Baltazar Gomez-Mancilla; David Hessl; Eva Loth; Sebastian H Scharf; Paul P Wang; Florian Von Raison; Randi Hagerman; Will Spooren; Sébastien Jacquemont
Journal:  Nat Rev Drug Discov       Date:  2017-12-08       Impact factor: 84.694

5.  Medication Repurposing in Pediatric Patients: Teaching Old Drugs New Tricks.

Authors:  Martha M Rumore
Journal:  J Pediatr Pharmacol Ther       Date:  2016 Jan-Feb

Review 6.  Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.

Authors:  Mary M Robertson
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-02       Impact factor: 4.785

Review 7.  Advances in the treatment of fragile X syndrome.

Authors:  Randi J Hagerman; Elizabeth Berry-Kravis; Walter E Kaufmann; Michele Y Ono; Nicole Tartaglia; Ave Lachiewicz; Rebecca Kronk; Carol Delahunty; David Hessl; Jeannie Visootsak; Jonathan Picker; Louise Gane; Michael Tranfaglia
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

8.  The Assessment and Treatment of Sleep Abnormalities in Children and Adolescents with Autism Spectrum Disorder: A Review.

Authors:  Mandeep Rana; Sanjeev Kothare; William DeBassio
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2021-02-01

Review 9.  Biological correlates of altered circadian rhythms, autonomic functions and sleep problems in autism spectrum disorder.

Authors:  Liliana Dell'Osso; Leonardo Massoni; Simone Battaglini; Ivan Mirko Cremone; Claudia Carmassi; Barbara Carpita
Journal:  Ann Gen Psychiatry       Date:  2022-05-09       Impact factor: 3.455

Review 10.  Identification and Treatment of Pathophysiological Comorbidities of Autism Spectrum Disorder to Achieve Optimal Outcomes.

Authors:  Richard E Frye; Daniel A Rossignol
Journal:  Clin Med Insights Pediatr       Date:  2016-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.